Rush David
University of Manitoba, Faculty of Medicine, Department of Internal Medicine, Section of Nephrology, Health Sciences Centre, Winnipeg, MB, Canada.
Saudi J Kidney Dis Transpl. 2010 Jan;21(1):1-9.
Protocol biopsies in renal transplantation are those that are procured at predetermined times post renal transplantation, regardless of renal function. These biopsies have been useful to study the natural history of the transplanted kidney as they have detected unexpected - i.e. "subclinical" pathology. The most significant subclinical pathologies that have been detected with protocol biopsies have been acute lesions, such as cellular and antibody mediated rejection, and chronic lesions, such as interstitial fibrosis and tubular atrophy, and transplant glomerulopathy. The potential benefit of early recognition of the above lesions is that their early treatment may result in improved long-term outcomes. Conversely, the identification of normal histology on a protocol biopsy, may inform us about the safety of reduction in overall immunosuppression. Our centre, as well as others, is attempting to develop non-invasive methods of immune monitoring of renal transplant patients. However, we believe that until such methods have been developed and validated, the protocol biopsy will remain an indispensable tool for the complete care of renal transplant patients.
肾移植中的方案活检是指在肾移植术后预定时间获取的活检,无论肾功能如何。这些活检对于研究移植肾的自然病程很有用,因为它们能检测到意外的——即“亚临床”病理情况。通过方案活检检测到的最显著的亚临床病理情况包括急性病变,如细胞介导性排斥和抗体介导性排斥,以及慢性病变,如间质纤维化、肾小管萎缩和移植肾小球病。早期识别上述病变的潜在益处在于,早期治疗可能会改善长期预后。相反,方案活检中发现正常组织学情况,可能会让我们了解降低整体免疫抑制的安全性。我们中心以及其他一些中心正在尝试开发肾移植患者免疫监测的非侵入性方法。然而,我们认为在这些方法得到开发和验证之前,方案活检仍将是全面护理肾移植患者不可或缺的工具。